Cureus | Surgery for Cystadenoma of the Retromolar Pad Area With Reconstruction Using a Buccal Fat Pad Flap: A Case Report

2022-08-13 02:14:25 By : Mr. Robin Huang

"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.

The SIQ for this article will be revealed

retromolar pad area, reconstructive surgery, salivary gland tumor, cystadenoma, buccal fat pad flap

Yukio Watabe , Shota Shinagawa, Shiro Shigematsu

Cite this article as: Watabe Y, Shinagawa S, Shigematsu S (July 26, 2022) Surgery for Cystadenoma of the Retromolar Pad Area With Reconstruction Using a Buccal Fat Pad Flap: A Case Report. Cureus 14(7): e27314. doi:10.7759/cureus.27314

Salivary gland tumors can also occur rarely in the retromolar area, though common near the junction of hard and soft palate, labial mucosa, and buccal mucosa. Most salivary gland tumors in the retromolar pad area are malignant and should be excised. The cystadenoma is a rare, benign, salivary gland tumor. Importantly, incomplete resection of this tumor can lead to recurrence or cervical lymph node metastasis. We reported herein a case of cystadenoma arising in the right retromolar pad area in a 63-year-old male patient who underwent reconstruction using a buccal fat pad flap (BFPF) after the surgical removal of the tumor with a 10-mm margin left a defect with bone exposure. No evidence of recurrence or complication was found at the postoperative, three-year follow-up.

Salivary gland tumors are relatively rare in the oral cavity but can potentially affect the minor salivary glands significantly. Minor salivary gland tumors comprise fewer than 25% of salivary gland tumors [1]. The cystadenoma is a rare, benign, salivary gland tumor and accounts for 4% of salivary gland neoplasms [2]. It commonly arises on the hard palate, buccal mucosa, or rarely in the retromolar pad area [3-5]. The recommended treatment for a cystadenoma is complete surgical resection [6], but reconstruction of the retromolar pad area is critical to maintaining the function of the oral cavity.

The buccal fat pad flap (BFPF) is a reliable and straightforward method of treating intraoral soft tissue defects. It has been used to reconstruct maxillary defects induced by tumors since it was first reported in 1977 [7]. We herein describe a surgically resected cystadenoma for which reconstruction using a BFPF was performed to correct a defect with bone exposure left by the resection.

A 63-year-old male patient was referred by his dentist to our hospital to treat an asymptomatic mass in the right retromolar pad area, which was discovered incidentally during dental treatment. There was no history of oral surgery and oral trauma. The patient had no history of smoking or alcohol consumption and no exposure to environmental carcinogens. Clinical examination revealed a mass of 17 mm x 10 mm without tenderness and a reddish area with discrete papules bordered by a peripheral whitish area on the lingual aspect in the right retromolar pad area (Figure 1).

The patient’s mouth opening was unconstrained. The patient had no difficulties in swallowing and eating. The patient had a history of hyperuricemia. Orthopantomography revealed no erosive destruction or changes in the trabecular bone marrow pattern in mandibular alveolar bone and no presence of radiolucency beneath the radiopaque-filling material involving the underlying pulp with an ill-defined radiolucency with loss of lamina dura in periapical root region of 19 (International Tooth Numbering System), suggestive of secondary caries with a chronic periapical abscess in the mandible (Figure 2).

Contrast-enhanced magnetic resonance imaging (MRI) with short tau (TI) inversion recovery demonstrated a hypointense lesion with a sharp margin, round shape, and uniform density distribution lesion in the right retromolar area, which was 13 mm x 10 mm in size and had not invaded the surrounding tissue (Figure 3).

Squamous cell carcinoma or malignant salivary gland tumor was provisionally diagnosed. An incisional biopsy was performed, and a sialadenoma papilliferum was diagnosed. However, since salivary gland tumors in the retromolar pad area are more frequently malignant tumors, total excision under general anesthesia was planned. The procedure included a wide tumor excision with a 10-mm margin. Because of its proximity to 47, the tooth was extracted. The inferior alveolar nerve was preserved during mass resection.

With mandibular bone exposure, the resection resulted in a sizable oral defect in the retromolar pad area. The oral defect was reconstructed using a BFPF (Figure 4, Panel A). Submucosa from the resection margin of the buccal mucosa was peeled and elevated cranially. The buccal muscle was incised cranially at the pterygomandibular ligament, and the buccal fat pad (BFP) was identified anterior to the medial pterygoid muscle. Blunt dissection was done, and the BFP pulled out anteriorly toward the oral defect without tension. The flap margin was sutured and fixed to the marginal oral mucosa with 4-0 nylon. The oral defect in the retromolar pad area was covered entirely with the BFP (Figure 4, Panel B). No additional skin grafting was performed because BFP flaps epithelialize spontaneously.

A thorough examination of the excised specimen led to the diagnosis of a cystadenoma (Figure 5, Panels A and B).

Surgical antibiotic prophylaxis (ampicillin 3.0 g/day) was administered until the day after surgery. The patient began a dysphagia soft diet the day after surgery. Mouth opening exercises were started in the early postoperative period. The postoperative course was uneventful, and the patient’s mouth opening was unconstrained. No recurrence was found at the three-year follow-up (Figure 6).

We reported a rare case of cystadenoma in the retromolar pad area. It should be borne in mind that a neoplastic lesion developing in the retromolar pad area may be a malignant salivary gland tumor. Therefore, in the present case, we performed a wide resection and reconstructed the surgical defect using a BFPF with good outcomes.

Cystadenomas, which arise in the pancreas, ovary, prostate, or kidney [8-11], rarely occur in the retromolar pad area. When it occurs in the head and neck area, it is often found in the parotid gland, with a frequency of 45% [12]. The most frequent sites of cystadenoma development in the oral cavity are the hard palate, the buccal mucosa, and the tongue [13], and rarely, the retromolar pad area [3-5]. Table 1 summarizes the case reports of cystadenoma in the retromolar pad area published in English since 2000.

In general, it was predominantly found in females [2]. Table 1 indicated no gender difference in the case of cystadenomas in the retromolar pad area. Some reports indicated no gender difference in the frequency of lesions [14]. Standard features of benign salivary gland tumors, including cystadenoma on CT and MRI, are sharp margins, round shape, and uniform density distribution [15]. In this case, findings characteristic of a benign salivary gland tumor were observed on MRI. However, most salivary gland tumors in the retromolar pad area are malignant [16], and a wide resection under general anesthesia was ultimately performed.

The wide excision in our patient left a defect with mandibular bone exposure in the retromolar pad area, which was corrected using a BFPF. The BFPF has the advantage of being simple and easy to perform. The BFP consists of the main body with four extensions: the temporal, buccal, pterygoid, and pterygopalatine processes [17]. Generally, the BFP can easily be accessed via a horizontal incision over the periosteum near the maxillary third molar [18]. After the resection, the BFP was easily accessed in the present case by dissecting and elevating the buccal mucosa and incising the exposed buccal muscle in the surgical field. The failure rate of reconstructive procedures for oral defects using BFPF is low, thanks to the tissue's rich vascularization and rapid epithelialization [19].

According to a review of 12 studies, 89.1% of BFPF reconstructions had no associated adverse events, including infection, loss of graft, bleeding, fistula, dehiscence, and mouth opening limitation [20]. However, the BFPF has several shortcomings. First, the size of the defect that can be corrected with this procedure is less than 5 cm in diameter [21]. Importantly, constriction of mouth opening is a postoperative complication associated with reconstructive surgery using a BFPF. In a retrospective study, five of 32 patients with reconstruction using a BFPF for an oral defect after tumor resection had scar retraction and constriction of mouth opening. After reconstructive oral surgery using a BFPF, mouth opening training should be started on postoperative day 5 to avoid these complications [22].

In this case, the biopsy result was sialadenoma papilliferum. However, the resected specimen was finally diagnosed as a cystadenoma. Sialadenoma papilliferum usually occurred at the junction of the hard and soft palates and the floor of the mouth and histopathologically did not show multiple cystic cavities [23]. The histopathologic differential diagnosis of cystadenoma includes Warthin's tumor and cystadenocarcinoma. Warthin's tumor is characterized by subepithelial aggregates of lymphocytes and germinal centers. These characteristics were not observed in this case. Furthermore, there was no evidence of invasive growth in the surrounding area, and findings suggestive of cystadenocarcinoma were lacking.

Most salivary gland tumors in the retromolar pad area are malignant [16]. Although the present case was a cystadenoma, an accurate diagnosis of the minor salivary gland is often difficult, even if the biopsy results indicate a benign tumor. For this reason, even a minor salivary gland tumor in the retromolar pad area should be excised. Resection is recommended in this disease, and recurrence or malignancy is rare [24]. However, a previous study reported a case of cystadenoma recurrence in the retromolar pad at postoperative year 5 with a simultaneous cervical metastasis [5]. Although cystadenomas are a benign form of salivary adenoma, providing a sufficiently wide surgical margin is warranted, as in the present case.

We experienced a case of cystadenoma occurring in the retromolar pad area, which was widely resected. The surgical defect was reconstructed using a BFPF. Most salivary gland tumors in the retromolar pad area are malignant, but a benign tumor may occasionally occur, as in the present case. Nonetheless, even a benign salivary gland tumor, especially a cystadenoma, should be excised completely to prevent a recurrence.

Department of Dentistry and Oral Surgery, Tokyo Metropolitan Tama Medical Center, Fuchu-shi, JPN

Department of Dentistry and Oral Surgery, Tokyo Metropolitan Tama Medical Center, Fuchu-shi, JPN

Department of Dentistry and Oral Surgery, Tokyo Metropolitan Tama Medical Center, Fuchu-shi, JPN

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

We are grateful to Mr. James R Valera for his assistance in editing the manuscript.

Watabe Y, Shinagawa S, Shigematsu S (July 26, 2022) Surgery for Cystadenoma of the Retromolar Pad Area With Reconstruction Using a Buccal Fat Pad Flap: A Case Report. Cureus 14(7): e27314. doi:10.7759/cureus.27314

Peer review began: March 14, 2022 Peer review concluded: July 25, 2022 Published: July 26, 2022

© Copyright 2022 Watabe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. Learn more here.

This link will take you to a third party website that is not affiliated with Cureus, Inc. Please note that Cureus is not responsible for any content or activities contained within our partner or affiliate websites.

Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. SIQ™ assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. All registered users are invited to contribute to the SIQ™ of any published article. (Authors cannot rate their own articles.)

High ratings should be reserved for work that is truly groundbreaking in its respective field. Anything above 5 should be considered above average. While all registered Cureus users can rate any published article, the opinion of domain experts is weighted appreciably more than that of non-specialists. An article’s SIQ™ will appear alongside the article after being rated twice and is recalculated with each additional rating.

Visit our SIQ™ page to find out more.

Scholarly Impact Quotient™ (SIQ™) is our unique post-publication peer review rating process. SIQ™ assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. All registered users are invited to contribute to the SIQ™ of any published article. (Authors cannot rate their own articles.)

Already have an account? Sign in.

Please note that by doing so you agree to be added to our monthly email newsletter distribution list.

By joining Cureus, you agree to our Privacy Policy and Terms of Use.